$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis 원문보기

Cancers, v.12 no.4, 2020년, pp.909 -   

Kwon, Ok-Seon (Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea) ,  Lee, Haeseung (Intellectual Information Team, Future Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea) ,  Kim, Yun-Jeong (College of Pharmacy, Seoul National University, Seoul 08826, Korea) ,  Cha, Hyuk-Jin (yunjkim36@gmail.com (Y.-J.K.)) ,  Song, Na-Young (hjcha93@snu.ac.kr (H.-J.C.)) ,  Lee, Mi-Ok (College of Pharmacy, Seoul National University, Seoul 08826, Korea)

Abstract AI-Helper 아이콘AI-Helper

The role of Situin 1 (SIRT1) in tumorigenesis is still controversial due to its wide range of substrates, including both oncoproteins and tumor suppressors. A recent study has demonstrated that SIRT1 interferes in the Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven activation of the Raf-mit...

Keyword

참고문헌 (52)

  1. 1. Nemoto S. Fergusson M.M. Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J. Biol. Chem. 2005 280 16456 16460 10.1074/jbc.M501485200 15716268 

  2. 2. Lee I.H. Cao L. Mostoslavsky R. Lombard D.B. Liu J. Bruns N.E. Tsokos M. Alt F.W. Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy Proc. Natl. Acad. Sci. USA 2008 105 3374 3379 10.1073/pnas.0712145105 18296641 

  3. 3. Kim J.J. Gil N.Y. Zhang X.H. Chun K.H. Fang G. Kim J. Cho H. Jang C.Y. Cha H.J. Sirt1 Regulates microtubule dynamics through negative regulation of Plk1 in mitosis J. Cell. Biochem. 2015 116 1888 1897 10.1002/jcb.25144 25737075 

  4. 4. Deng C.X. SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 2009 5 147 152 10.7150/ijbs.5.147 19173036 

  5. 5. Song N.Y. Surh Y.J. Janus-faced role of SIRT1 in tumorigenesis Ann. N. Y. Acad. Sci. 2012 1271 10 19 10.1111/j.1749-6632.2012.06762.x 23050959 

  6. 6. Cheng H.L. Mostoslavsky R. Saito S. Manis J.P. Gu Y. Patel P. Bronson R. Appella E. Alt F.W. Chua K.F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc. Natl. Acad. Sci. USA 2003 100 10794 10799 10.1073/pnas.1934713100 12960381 

  7. 7. Lee J.S. Park J.R. Kwon O.S. Lee T.H. Nakano I. Miyoshi H. Chun K.H. Park M.J. Lee H.J. Kim S.U. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner Neuro-Oncology 2015 17 95 106 10.1093/neuonc/nou145 25096191 

  8. 8. Motta M.C. Divecha N. Lemieux M. Kamel C. Chen D. Gu W. Bultsma Y. McBurney M. Guarente L. Mammalian SIRT1 represses forkhead transcription factors Cell 2004 116 551 563 10.1016/S0092-8674(04)00126-6 14980222 

  9. 9. Huffman D.M. Grizzle W.E. Bamman M.M. Kim J.S. Eltoum I.A. Elgavish A. Nagy T.R. SIRT1 is significantly elevated in mouse and human prostate cancer Cancer Res. 2007 67 6612 6618 10.1158/0008-5472.CAN-07-0085 17638871 

  10. 10. Stunkel W. Peh B.K. Tan Y.C. Nayagam V.M. Wang X. Salto-Tellez M. Ni B. Entzeroth M. Wood J. Function of the SIRT1 protein deacetylase in cancer Biotechnol. J. 2007 2 1360 1368 10.1002/biot.200700087 17806102 

  11. 11. Ford J. Jiang M. Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival Cancer Res. 2005 65 10457 10463 10.1158/0008-5472.CAN-05-1923 16288037 

  12. 12. Song S.-H. Lee M.-O. Lee J.-S. Oh J.-S. Cho S.-U. Cha H.-J. Sirt1 promotes DNA damage repair and cellular survival Biomol. Ther. 2011 19 282 287 10.4062/biomolther.2011.19.3.282 

  13. 13. Uhl M. Csernok A. Aydin S. Kreienberg R. Wiesmuller L. Gatz S.A. Role of SIRT1 in homologous recombination DNA Repair (Amsterdam) 2010 9 383 393 10.1016/j.dnarep.2009.12.020 20097625 

  14. 14. Lin Y.H. Yuan J. Pei H. Liu T. Ann D.K. Lou Z. KAP1 Deacetylation by SIRT1 promotes non-homologous end-joining repair PLoS ONE 2015 10 e0123935 10.1371/journal.pone.0123935 25905708 

  15. 15. Wang R.H. Sengupta K. Li C. Kim H.S. Cao L. Xiao C. Kim S. Xu X. Zheng Y. Chilton B. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice Cancer Cell 2008 14 312 323 10.1016/j.ccr.2008.09.001 18835033 

  16. 16. Costa-Machado L.F. Martin-Hernandez R. Sanchez-Luengo M.A. Hess K. Vales-Villamarin C. Barradas M. Lynch C. de la Nava D. Diaz-Ruiz A. de Cabo R. Sirt1 protects from K-Ras-driven lung carcinogenesis EMBO Rep. 2018 19 10.15252/embr.201643879 

  17. 17. Pylayeva-Gupta Y. Grabocka E. Bar-Sagi D. RAS oncogenes: Weaving a tumorigenic web Nat. Rev. Cancer 2011 11 761 774 10.1038/nrc3106 21993244 

  18. 18. Khalaf W.F. White H. Wenning M.J. Orazi A. Kapur R. Ingram D.A. K-Ras is essential for normal fetal liver erythropoiesis Blood 2005 105 3538 3541 10.1182/blood-2004-05-2021 15644420 

  19. 19. Bos J.L. Ras oncogenes in human cancer: A review Cancer Res. 1989 49 4682 4689 2547513 

  20. 20. Prior I.A. Lewis P.D. Mattos C. A comprehensive survey of Ras mutations in cancer Cancer Res. 2012 72 2457 2467 10.1158/0008-5472.CAN-11-2612 22589270 

  21. 21. Hanahan D. Weinberg R.A. Hallmarks of cancer: The next generation Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230 

  22. 22. Chambard J.C. Lefloch R. Pouyssegur J. Lenormand P. ERK implication in cell cycle regulation Biochim. Biophys. Acta 2007 1773 1299 1310 10.1016/j.bbamcr.2006.11.010 17188374 

  23. 23. Braig M. Schmitt C.A. Oncogene-induced senescence: Putting the brakes on tumor development Cancer Res. 2006 66 2881 2884 10.1158/0008-5472.CAN-05-4006 16540631 

  24. 24. Bulavin D.V. Fornace A.J. Jr. p38 MAP kinase’s emerging role as a tumor suppressor Adv. Cancer Res. 2004 92 95 118 10.1016/S0065-230X(04)92005-2 15530558 

  25. 25. Cuenda A. Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases Biochim. Biophys. Acta 2007 1773 1358 1375 10.1016/j.bbamcr.2007.03.010 17481747 

  26. 26. Westermarck J. Li S.P. Kallunki T. Han J. Kahari V.M. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression Mol. Cell. Biol. 2001 21 2373 2383 10.1128/MCB.21.7.2373-2383.2001 11259586 

  27. 27. Li S.P. Junttila M.R. Han J. Kahari V.M. Westermarck J. p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2 Cancer Res. 2003 63 3473 3477 10.1158/0008-5472.CAN-19-3320 12839928 

  28. 28. Wancket L.M. Frazier W.J. Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease Life Sci. 2012 90 237 248 10.1016/j.lfs.2011.11.017 22197448 

  29. 29. Kidger A.M. Keyse S.M. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs) Semin. Cell Dev. Biol. 2016 50 125 132 10.1016/j.semcdb.2016.01.009 26791049 

  30. 30. Shapiro P.S. Ahn N.G. Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1) J. Biol. Chem. 1998 273 1788 1793 10.1074/jbc.273.3.1788 9430728 

  31. 31. Sun H. Tonks N.K. Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1 Science 1994 266 285 288 10.1126/science.7939666 7939666 

  32. 32. Bang Y.J. Kwon J.H. Kang S.H. Kim J.W. Yang Y.C. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma Biochem. Biophys. Res. Commun. 1998 250 43 47 10.1006/bbrc.1998.9256 9735328 

  33. 33. Manzano R.G. Montuenga L.M. Dayton M. Dent P. Kinoshita I. Vicent S. Gardner G.J. Nguyen P. Choi Y.H. Trepel J. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential Oncogene 2002 21 4435 4447 10.1038/sj.onc.1205542 12080474 

  34. 34. Shen J. Zhang Y. Yu H. Shen B. Liang Y. Jin R. Liu X. Shi L. Cai X. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy Cancer Med. 2016 5 2061 2068 10.1002/cam4.772 27227569 

  35. 35. Wu J.J. Bennett A.M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling J. Biol. Chem. 2005 280 16461 16466 10.1074/jbc.M501762200 15722358 

  36. 36. Moncho-Amor V. Ibanez de Caceres I. Bandres E. Martinez-Poveda B. Orgaz J.L. Sanchez-Perez I. Zazo S. Rovira A. Albanell J. Jimenez B. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer Oncogene 2011 30 668 678 10.1038/onc.2010.449 20890299 

  37. 37. Liao Q. Guo J. Kleeff J. Zimmermann A. Buchler M.W. Korc M. Friess H. Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells Gastroenterology 2003 124 1830 1845 10.1016/S0016-5085(03)00398-6 12806617 

  38. 38. Vicent S. Garayoa M. Lopez-Picazo J.M. Lozano M.D. Toledo G. Thunnissen F.B. Manzano R.G. Montuenga L.M. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients Clin. Cancer Res. 2004 10 3639 3649 10.1158/1078-0432.CCR-03-0771 15173070 

  39. 39. Wang H.Y. Cheng Z. Malbon C.C. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer Cancer Lett. 2003 191 229 237 10.1016/S0304-3835(02)00612-2 12618338 

  40. 40. Cao W. Bao C. Padalko E. Lowenstein C.J. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits toll-like receptor signaling J. Exp. Med. 2008 205 1491 1503 10.1084/jem.20071728 18504304 

  41. 41. Roberts P.J. Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 2007 26 3291 3310 10.1038/sj.onc.1210422 17496923 

  42. 42. Chi H. Flavell R.A. Acetylation of MKP-1 and the control of inflammation Sci. Signal. 2008 1 pe44 10.1126/scisignal.141pe44 18922786 

  43. 43. Pages G. MAP kinase phosphatase-1: A link between cell signaling and histone phosphorylation. Focus on “Histone H3 as a novel substrate for MAP kinase phosphatase-1.” Am. J. Physiol. Cell Physiol. 2009 296 C233 C234 10.1152/ajpcell.00637.2008 19109521 

  44. 44. Tanoue T. Yamamoto T. Nishida E. Modular structure of a docking surface on MAPK phosphatases J. Biol. Chem. 2002 277 22942 22949 10.1074/jbc.M202096200 11953434 

  45. 45. Eberharter A. Becker P.B. Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics EMBO Rep. 2002 3 224 229 10.1093/embo-reports/kvf053 11882541 

  46. 46. Narita T. Weinert B.T. Choudhary C. Functions and mechanisms of non-histone protein acetylation Nat. Rev. Mol. Cell Biol. 2019 20 156 174 10.1038/s41580-018-0081-3 30467427 

  47. 47. Grimes M. Hall B. Foltz L. Levy T. Rikova K. Gaiser J. Cook W. Smirnova E. Wheeler T. Clark N.R. Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks Sci. Signal. 2018 11 eaaq1087 10.1126/scisignal.aaq1087 29789295 

  48. 48. Sestito R. Madonna S. Scarponi C. Cianfarani F. Failla C.M. Cavani A. Girolomoni G. Albanesi C. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation FASEB J. 2011 25 916 927 10.1096/fj.10-172288 21098725 

  49. 49. Bartlett T.E. Zaikin A. Olhede S.C. West J. Teschendorff A.E. Widschwendter M. Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer PLoS ONE 2013 8 e68285 10.1371/journal.pone.0068285 23874574 

  50. 50. Kondoh K. Nishida E. Regulation of MAP kinases by MAP kinase phosphatases Biochim. Biophys. Acta 2007 1773 1227 1237 10.1016/j.bbamcr.2006.12.002 17208316 

  51. 51. Chi H. Barry S.P. Roth R.J. Wu J.J. Jones E.A. Bennett A.M. Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses Proc. Natl. Acad. Sci. USA 2006 103 2274 2279 10.1073/pnas.0510965103 16461893 

  52. 52. Zhao Q. Wang X. Nelin L.D. Yao Y. Matta R. Manson M.E. Baliga R.S. Meng X. Smith C.V. Bauer J.A. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock J. Exp. Med. 2006 203 131 140 10.1084/jem.20051794 16380513 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로